3 days of dosing are required
- For patients at risk of CINV due to HEC or MEC, EMEND always should be taken on Days 1, 2, and 3 of each cycle, in combination with a 5-HT3 receptor antagonist and a corticosteroid, even if patients do not experience nausea and vomiting on Day 1.
- All 3 doses of EMEND are required for the full 5 days of CINV protection.
Realize the full benefit
Talk with your patients
- Explain the importance of taking EMEND on Days 2 and 3 of every cycle, even if patients do not experience nausea and vomiting on Day 1.
- Remember that the ACT Program is available to provide assistance to qualified patients.
-
Ensure that managed care and Medicare patients know that EMEND usually is covered:
EMEND has favorable formulary status
- 96% of patients with managed care plans have EMEND on Tier 2 or Tier 3.
- 100% of patients with Medicare Part D plans have EMEND on Tier 2 or Tier 3.
| Common Copayments for EMEND | ||
| Plan Coverage for EMEND | National Copayment | |
|---|---|---|
| Managed care plans | Tier 2 status for 73% of covered lives | $241 |
| Tier 3 status for 23% of covered lives | $451 | |
| Medicare Part D plans | Tier 2 status for 75% of covered lives | $301,a |
| Tier 3 status for 25% of covered lives | $601,a | |
aThe table shows the most common copayment amount as the mode, not the average, for Medicare products.
For information about Merck products or services, please call 866-448-7590. The Merck National Service Center will be pleased to assist you Monday through Friday from 8 AM to 7 PM ET.
